Natural attack rate of influenza in unvaccinated children and adults: A meta-regression analysis

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Jayasundara, Kavisha ^a   Soobiah, Charlene ^b   Thommes, Edward ^a,c   Tricco, Andrea C ^b,d   Chit, Ayman ^a,e  

^a GLAXOSMITHKLINE   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e Sanofi Pasteur   (Canada)

Author keywords

Healthy individuals; Influenza A; Influenza B; Natural attack rate; Systematic review

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ASIA; AUSTRALIA; CHILD; EUROPE; HUMAN; INFECTION RATE; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; NORTH AMERICA; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; SEASONAL VARIATION; SOUTH AMERICA; SYSTEMATIC REVIEW (TOPIC); VIRUS STRAIN; AGE; COST BENEFIT ANALYSIS; FEMALE; INCIDENCE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; META ANALYSIS; REGRESSION ANALYSIS; RISK FACTOR; SEASON; VIROLOGY;

ADULT; AGE FACTORS; CHILD; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INCIDENCE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; REGRESSION ANALYSIS; RISK FACTORS; SEASONS;

EID: 84923865188     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0670-5     Document Type: Article

References (22)

1. Eisenberg JN, Brookhart MA, Rice G, Brown M, Colford JM Jr: Disease transmission models for public health decision making: analysis of epidemic and endemic conditions caused by waterborne pathogens. Environ Health Perspect 2002, 110:783-790.
2. Keeling MJ, Rohani P: Modeling Infectious Diseases in Humans and Animals. Princeton University Press; 2007
3. Vynnycky E, White R: An Introduction to Infectious Disease Modelling. Oxford University Press; 2010
4. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB: The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007, 25:5086-5096.
5. Lee VJ, Chen MI, Yap J, Ong J, Lim WY, Lin RT, Barr I, Ong JB, Mak TM, Goh LG, Leo YS, Kelly PM, Cook AR: Comparability of different methods for estimating influenza infection rates over a single epidemic wave. Am J Epidemiol 2011, 174:468-478.
6. Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K: Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 2003, 7:iii-xiii, 1.
7. Tricco AC, Chit A, Soobiah C, Hallett D, Meier G, Chen MH, Tashkandi M, Bauch CT, Loeb M: Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med 2013, 11:153.
8. Tricco AC, Chit A, Hallett D, Soobiah C, Meier G, Chen M, Tashkandi M, Bauch C, Loeb M: Effect of influenza vaccines against mismatched strains: a systematic review protocol. Syst Rev 2012, 1:35.
9. Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, Halperin I, Vachon B, Ramsay T, Manns B, Tonelli M, Shojania K: Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet 2012, 379:2252-2261.
10. Allemann S, Houriet C, Diem P, Stettler C: Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis. Curr Med Res Opin 2009, 25:2903-2913.
11. Reed C, Meltzer MI, Daily Kirley P, Emerson R, Aragon D, Hancock E, Butler L, Baumbach J, Hollick G, Bennett N, Phoutrides E, Laidler M, Finelli L: Progress toward routine estimation of the seasonal burden of influenza in the United States [Abstract]. In 49 th Annual Meeting of the Infectious Diseases Society of America, Boston, MA; Abstract #1122; 2011.
12. WHO: Influenza Fact Sheet [ http://www.who.int/mediacentre/factsheets/fs211/en/ ]
13. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ: Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008, 5:E74.
14. Mathews JD, Chesson JM, McCaw JM, McVernon J: Understanding influenza transmission, immunity and pandemic threats. Influenza Other Respi Viruses 2009, 3:143-149.
15. Osterhaus A, De Pooter D: 101 Questions & Answers On Influenza. Maarssen: Elsevier; 2009.
16. Hay AJ, Gregory V, Douglas AR, Lin YP: The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 2001, 356:1861-1870.
17. Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS: Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis 2011, 203:1309-1315.
18. Couch R: Vaccines and Related Biological Products Advisory Committee [ http://www.fda.gov/ohrms/dockets/ac/07/slides/2007-4282s2_11_files/frame.htm ]
19. Glatman-Freedman A, Portelli I, Jacobs SK, Mathew JI, Slutzman JE, Goldfrank LR, Smith SW: Attack rates assessment of the 2009 pandemic H1N1 influenza A in children and their contacts: a systematic review and meta-analysis. PLoS One 2012, 7:E50228.
20. Talaat KR, Greenberg ME, Lai MH, Hartel GF, Wichems CH, Rockman S, Jeanfreau RJ, Ghosh MR, Kabongo ML, Gittleson C, Karron RA: A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults. J Infect Dis 2010, 202:1327-1337.
21. Vynnycky E, Pitman R, Siddiqui R, Gay N, Edmunds WJ: Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine 2008, 26:5321-5330.
22. Fisman DN, Tuite AR: Estimation of the health impact and cost-effectiveness of influenza vaccination with enhanced effectiveness in Canada. PLoS One 2011, 6:E27420.